Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials

Main Article Content

K Reich
A Blauvelt
M Lebwohl
KA Papp
P Rich
B Strober
D De Cuyper
C Madden
L Peterson
V Vanvoorden
RB Warren


Plaque Psoriasis, Biologic, Bimekizumab, Safety


Abstract not available.


1. Glatt S. Br J Clin Pharmacol 2017;83:991–1001

2. Papp KA. J Am Acad Dermatol 2018;79:277–86 e10.

Most read articles by the same author(s)

1 2 3 4 5 > >>